Group One Trading
CNST

Group One Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Group One Trading’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,800
Closed -$534K – 9153
2021
Q2 		$534K Buy
15,800
+13,000
+464% +$331K ﹤0.01% 4162
2021
Q1 		$65K Buy
2,800
+2,600
+1,300% +$78.8K ﹤0.01% 6043
2020
Q4 		$6K Sell
200
-4,800
-96% -$121K ﹤0.01% 5995
2020
Q3 		$101K Hold
5,000
– – ﹤0.01% 4190
2020
Q2 		$150K Buy
+5,000
New +$180K ﹤0.01% 3612

Group One Trading's CNST Position: Q3 2020 in Review

Group One Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2020, closing a stake of 13 shares — an estimated $317 sold.

Group One Trading first reported a position in CNST in Q4 2019 and held it in 3 quarters. The position peaked at $10K in Q4 2019. 119 funds tracked by Wall St. Rank hold CNST as of Q3 2020.

  • Group One Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Group One Trading sold 13 Constellation Pharmaceuticals, Inc. shares in Q3 2020, an estimated $317.
  • Group One Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
  • Group One Trading's Constellation Pharmaceuticals, Inc. position peaked at $10K in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2020.

Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.